NeuroSense Therapeutics Ltd. (NRSN)
NASDAQ: NRSN · Real-Time Price · USD
0.809
+0.058 (7.78%)
At close: Apr 28, 2026, 4:00 PM EDT
0.809
0.00 (0.00%)
Pre-market: Apr 29, 2026, 8:41 AM EDT
NeuroSense Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 29 | 23 | 28 | 11 | 14 | 26 | |
| Market Cap Growth | 12.45% | -17.70% | 158.68% | -24.68% | -46.24% | - | |
| Enterprise Value | 29 | 22 | 27 | 6 | 6 | 25 | |
| Last Close Price | 0.81 | 0.77 | 1.20 | 0.79 | 1.22 | 2.46 | |
| PB Ratio | - | -14.64 | 10.74 | -6.10 | 2.44 | 2.94 | |
| P/TBV Ratio | - | - | 10.74 | - | 2.44 | 2.94 | |
| Debt / Equity Ratio | -0.11 | -0.11 | 0.03 | -0.08 | 0.04 | - | |
| Net Debt / Equity Ratio | 0.00 | 0.00 | -1.28 | 1.42 | -1.18 | -1.23 | |
| Net Debt / EBITDA Ratio | 0 | 0 | 0.34 | 0.21 | 0.65 | 3.71 | |
| Net Debt / FCF Ratio | 0.00 | 0.00 | 0.33 | 0.30 | 0.90 | 7.11 | |
| Quick Ratio | 0.08 | 0.08 | 1.78 | 0.81 | 4.18 | 18.83 | |
| Current Ratio | 0.31 | 0.31 | 2.21 | 0.84 | 4.28 | 19.12 | |
| Return on Equity (ROE) | -2174.97% | -2174.97% | -2478.15% | -494.83% | -141.31% | -66.63% | |
| Return on Assets (ROA) | -247.30% | -247.30% | -159.50% | -138.15% | -68.90% | -30.56% | |
| Return on Capital Employed (ROCE) | 745.00% | 745.00% | -383.40% | 4397.40% | -176.20% | -27.60% | |
| Earnings Yield | -38.91% | -48.71% | -36.79% | -94.21% | -73.67% | -12.16% | |
| FCF Yield | -26.85% | -33.62% | -36.53% | -78.14% | -53.97% | -5.87% | |
| Buyback Yield / Dilution | -36.98% | -36.98% | -36.38% | -18.56% | -84.27% | -13.13% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.